Ayurcann Holdings Corp. reported earnings results for the third quarter and nine months ended March 31, 2022. For the third quarter, the company reported revenue was CAD 2.76 million compared to CAD 2.63 million a year ago. Net loss was CAD 0.548638 million compared to CAD 0.974615 million a year ago. Basic loss per share from continuing operations was CAD 0.005 compared to CAD 0.011 a year ago.
For the nine months, revenue was CAD 7.83 million compared to CAD 4.97 million a year ago. Net loss was CAD 0.639243 million compared to CAD 1.32 million a year ago. Basic loss per share from continuing operations was CAD 0.005 compared to CAD 0.017 a year ago.